{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:03:25Z","timestamp":1784815405545,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.taap.2026.117776","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:48:40Z","timestamp":1772207320000},"page":"117776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RUNDC3A-AS1 is an adverse prognostic factor for triple-negative breast cancer which mediates the Warburg effect and Adriamycin resistance by targeting miR-224-3p\/COL5A2"],"prefix":"10.1016","volume":"511","author":[{"given":"Linna","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2026.117776_bb0005","first-page":"511","article-title":"LncRNA polymorphisms and lung cancer risk","volume":"20","author":"Abdi","year":"2023","journal-title":"Perinat. Med."},{"issue":"17","key":"10.1016\/j.taap.2026.117776_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179644","article-title":"New advances in the research of resistance to neoadjuvant chemotherapy in breast Cancer","volume":"22","author":"An","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.taap.2026.117776_bb0015","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s12094-022-03059-4","article-title":"LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p","volume":"25","author":"Buranjiang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"2","key":"10.1016\/j.taap.2026.117776_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11010-022-04507-z","article-title":"SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines","volume":"478","author":"Chao","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.taap.2026.117776_bb0025","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.ymthe.2021.04.036","article-title":"FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect","volume":"29","author":"Chu","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.taap.2026.117776_bb0030","doi-asserted-by":"crossref","first-page":"9433434","DOI":"10.1155\/2022\/9433434","article-title":"lncRNA RUNDC3A-AS1 regulates proliferation and apoptosis of thyroid Cancer cells via the miR-151b\/SNRPB Axis","volume":"2022","author":"Deng","year":"2022","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.taap.2026.117776_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.gene.2015.12.028","article-title":"Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4","volume":"578","author":"Feng","year":"2016","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12951-025-03134-2","article-title":"Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.taap.2026.117776_bb0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/atm.2019.02.32","article-title":"Lactate and cancer: a \u201clactatic\u201d perspective on spinal tumor metabolism (part 1)","volume":"7","author":"Goodwin","year":"2019","journal-title":"Ann Transl Med."},{"issue":"9","key":"10.1016\/j.taap.2026.117776_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.taap.2026.117776_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41419-023-05628-z","article-title":"Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208","volume":"14","author":"Han","year":"2023","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.taap.2026.117776_bb0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.21037\/atm-22-3434","article-title":"The pathological and clinical landscape of refractory metastatic triple negative breast cancer: a narrative review","volume":"10","author":"Jiang","year":"2022","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.taap.2026.117776_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106641","article-title":"Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer","volume":"85","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.taap.2026.117776_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13321","article-title":"Proton pump inhibitors display anti-tumour potential in glioma","volume":"56","author":"Li","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.taap.2026.117776_bb0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S504629","article-title":"Design of pH-responsive nanomaterials based on the tumor microenvironment","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.taap.2026.117776_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2020.00005","article-title":"Metabolic Symbiosis in chemoresistance: refocusing the role of aerobic glycolysis","volume":"10","author":"Ma","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2026.117776_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.650004","article-title":"Long non-coding RNA RUNDC3A-AS1 promotes lung metastasis of thyroid Cancer via targeting the miR-182-5p\/ADAM9","volume":"9","author":"Ma","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2026.117776_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120810","article-title":"Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis","volume":"306","author":"Ma","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0095","first-page":"112","article-title":"Predictive significance of glycolysis-associated lncRNA profiles in colorectal cancer progression","volume":"17","author":"Mao","year":"2024","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.taap.2026.117776_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101496","article-title":"Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy","volume":"60","author":"Mascaraque-Checa","year":"2022","journal-title":"Mol Metab."},{"key":"10.1016\/j.taap.2026.117776_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115242","article-title":"Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies","volume":"165","author":"Mehmandar-Oskuie","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.117776_bb0110","doi-asserted-by":"crossref","first-page":"1004821","DOI":"10.3389\/fphar.2022.1004821","article-title":"Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: a systematic review and meta-analysis","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ph18010075","article-title":"Leveraging single-cell multi-omics to decode tumor microenvironment diversity and therapeutic resistance","volume":"18","author":"Sabit","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2026.117776_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147867","article-title":"Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in breast, colorectal and gastric cancers","volume":"892","author":"Salimian","year":"2024","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010230","article-title":"Auger emitter conjugated PARP inhibitor for therapy in triple negative breast cancers: a comparative in-vitro study","volume":"14","author":"Sankaranarayanan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-024-02399-5","article-title":"The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response","volume":"19","author":"Schwab","year":"2024","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.taap.2026.117776_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104550","article-title":"Cost-effectiveness of sacituzumab tirumotecan versus chemotherapy for patients with metastatic triple-negative breast cancer in China","volume":"83","author":"Shu","year":"2025","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.taap.2026.117776_bb0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41574-018-0146-6","article-title":"Fuelling cancer cells","volume":"15","author":"Terry","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-021-01332-8","article-title":"CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2026.117776_bb0150","doi-asserted-by":"crossref","first-page":"1388700","DOI":"10.3389\/fonc.2024.1388700","article-title":"The tumor-associated fibrotic reactions in microenvironment aggravate glioma chemoresistance","volume":"14","author":"Xu","year":"2024","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.taap.2026.117776_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/gtmb.2021.0259","article-title":"LncRNA PVT1 regulates miR-1207-5p to affect Colon Cancer proliferation and migration via the Wnt6\/beta-catenin2 pathway","volume":"26","author":"Yu","year":"2022","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.taap.2026.117776_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2021.05.016","article-title":"Exosomes and organ-specific metastasis","volume":"22","author":"Zhao","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.taap.2026.117776_bb0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12935-023-03160-w","article-title":"Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer","volume":"23","author":"Zhou","year":"2023","journal-title":"Cancer Cell Int."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:19:13Z","timestamp":1784812753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0041008X26000724"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117776","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUNDC3A-AS1 is an adverse prognostic factor for triple-negative breast cancer which mediates the Warburg effect and Adriamycin resistance by targeting miR-224-3p\/COL5A2","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117776"}}